Cargando…
The cost of implementing the COVID-19 shielding policy in Wales
BACKGROUND: The EVITE Immunity study investigated the effects of shielding Clinically Extremely Vulnerable (CEV) people during the COVID-19 pandemic on health outcomes and healthcare costs in Wales, United Kingdom, to help prepare for future pandemics. Shielding was intended to protect those at high...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680245/ https://www.ncbi.nlm.nih.gov/pubmed/38008730 http://dx.doi.org/10.1186/s12889-023-17169-3 |
_version_ | 1785150685591896064 |
---|---|
author | Sewell, Bernadette Farr, Angela Akbari, Ashley Carson-Stevens, Andrew Dale, Jeremy Edwards, Adrian Evans, Bridie Angela John, Ann Torabi, Fatemeh Jolles, Stephen Kingston, Mark Lyons, Jane Lyons, Ronan A. Porter, Alison Watkins, Alan Williams, Victoria Snooks, Helen |
author_facet | Sewell, Bernadette Farr, Angela Akbari, Ashley Carson-Stevens, Andrew Dale, Jeremy Edwards, Adrian Evans, Bridie Angela John, Ann Torabi, Fatemeh Jolles, Stephen Kingston, Mark Lyons, Jane Lyons, Ronan A. Porter, Alison Watkins, Alan Williams, Victoria Snooks, Helen |
author_sort | Sewell, Bernadette |
collection | PubMed |
description | BACKGROUND: The EVITE Immunity study investigated the effects of shielding Clinically Extremely Vulnerable (CEV) people during the COVID-19 pandemic on health outcomes and healthcare costs in Wales, United Kingdom, to help prepare for future pandemics. Shielding was intended to protect those at highest risk of serious harm from COVID-19. We report the cost of implementing shielding in Wales. METHODS: The number of people shielding was extracted from the Secure Anonymised Information Linkage Databank. Resources supporting shielding between March and June 2020 were mapped using published reports, web pages, freedom of information requests to Welsh Government and personal communications (e.g. with the office of the Chief Medical Officer for Wales). RESULTS: At the beginning of shielding, 117,415 people were on the shielding list. The total additional cost to support those advised to stay home during the initial 14 weeks of the pandemic was £13,307,654 (£113 per person shielded). This included the new resources required to compile the shielding list, inform CEV people of the shielding intervention and provide medicine and food deliveries. The list was adjusted weekly over the 3-month period (130,000 people identified by June 2020). Therefore the cost per person shielded lies between £102 and £113 per person. CONCLUSION: This is the first evaluation of the cost of the measures put in place to support those identified to shield in Wales. However, no data on opportunity cost was available. The true costs of shielding including its budget impact and opportunity costs need to be investigated to decide whether shielding is a worthwhile policy for future health emergencies. |
format | Online Article Text |
id | pubmed-10680245 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106802452023-11-26 The cost of implementing the COVID-19 shielding policy in Wales Sewell, Bernadette Farr, Angela Akbari, Ashley Carson-Stevens, Andrew Dale, Jeremy Edwards, Adrian Evans, Bridie Angela John, Ann Torabi, Fatemeh Jolles, Stephen Kingston, Mark Lyons, Jane Lyons, Ronan A. Porter, Alison Watkins, Alan Williams, Victoria Snooks, Helen BMC Public Health Research BACKGROUND: The EVITE Immunity study investigated the effects of shielding Clinically Extremely Vulnerable (CEV) people during the COVID-19 pandemic on health outcomes and healthcare costs in Wales, United Kingdom, to help prepare for future pandemics. Shielding was intended to protect those at highest risk of serious harm from COVID-19. We report the cost of implementing shielding in Wales. METHODS: The number of people shielding was extracted from the Secure Anonymised Information Linkage Databank. Resources supporting shielding between March and June 2020 were mapped using published reports, web pages, freedom of information requests to Welsh Government and personal communications (e.g. with the office of the Chief Medical Officer for Wales). RESULTS: At the beginning of shielding, 117,415 people were on the shielding list. The total additional cost to support those advised to stay home during the initial 14 weeks of the pandemic was £13,307,654 (£113 per person shielded). This included the new resources required to compile the shielding list, inform CEV people of the shielding intervention and provide medicine and food deliveries. The list was adjusted weekly over the 3-month period (130,000 people identified by June 2020). Therefore the cost per person shielded lies between £102 and £113 per person. CONCLUSION: This is the first evaluation of the cost of the measures put in place to support those identified to shield in Wales. However, no data on opportunity cost was available. The true costs of shielding including its budget impact and opportunity costs need to be investigated to decide whether shielding is a worthwhile policy for future health emergencies. BioMed Central 2023-11-26 /pmc/articles/PMC10680245/ /pubmed/38008730 http://dx.doi.org/10.1186/s12889-023-17169-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Sewell, Bernadette Farr, Angela Akbari, Ashley Carson-Stevens, Andrew Dale, Jeremy Edwards, Adrian Evans, Bridie Angela John, Ann Torabi, Fatemeh Jolles, Stephen Kingston, Mark Lyons, Jane Lyons, Ronan A. Porter, Alison Watkins, Alan Williams, Victoria Snooks, Helen The cost of implementing the COVID-19 shielding policy in Wales |
title | The cost of implementing the COVID-19 shielding policy in Wales |
title_full | The cost of implementing the COVID-19 shielding policy in Wales |
title_fullStr | The cost of implementing the COVID-19 shielding policy in Wales |
title_full_unstemmed | The cost of implementing the COVID-19 shielding policy in Wales |
title_short | The cost of implementing the COVID-19 shielding policy in Wales |
title_sort | cost of implementing the covid-19 shielding policy in wales |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680245/ https://www.ncbi.nlm.nih.gov/pubmed/38008730 http://dx.doi.org/10.1186/s12889-023-17169-3 |
work_keys_str_mv | AT sewellbernadette thecostofimplementingthecovid19shieldingpolicyinwales AT farrangela thecostofimplementingthecovid19shieldingpolicyinwales AT akbariashley thecostofimplementingthecovid19shieldingpolicyinwales AT carsonstevensandrew thecostofimplementingthecovid19shieldingpolicyinwales AT dalejeremy thecostofimplementingthecovid19shieldingpolicyinwales AT edwardsadrian thecostofimplementingthecovid19shieldingpolicyinwales AT evansbridieangela thecostofimplementingthecovid19shieldingpolicyinwales AT johnann thecostofimplementingthecovid19shieldingpolicyinwales AT torabifatemeh thecostofimplementingthecovid19shieldingpolicyinwales AT jollesstephen thecostofimplementingthecovid19shieldingpolicyinwales AT kingstonmark thecostofimplementingthecovid19shieldingpolicyinwales AT lyonsjane thecostofimplementingthecovid19shieldingpolicyinwales AT lyonsronana thecostofimplementingthecovid19shieldingpolicyinwales AT porteralison thecostofimplementingthecovid19shieldingpolicyinwales AT watkinsalan thecostofimplementingthecovid19shieldingpolicyinwales AT williamsvictoria thecostofimplementingthecovid19shieldingpolicyinwales AT snookshelen thecostofimplementingthecovid19shieldingpolicyinwales AT sewellbernadette costofimplementingthecovid19shieldingpolicyinwales AT farrangela costofimplementingthecovid19shieldingpolicyinwales AT akbariashley costofimplementingthecovid19shieldingpolicyinwales AT carsonstevensandrew costofimplementingthecovid19shieldingpolicyinwales AT dalejeremy costofimplementingthecovid19shieldingpolicyinwales AT edwardsadrian costofimplementingthecovid19shieldingpolicyinwales AT evansbridieangela costofimplementingthecovid19shieldingpolicyinwales AT johnann costofimplementingthecovid19shieldingpolicyinwales AT torabifatemeh costofimplementingthecovid19shieldingpolicyinwales AT jollesstephen costofimplementingthecovid19shieldingpolicyinwales AT kingstonmark costofimplementingthecovid19shieldingpolicyinwales AT lyonsjane costofimplementingthecovid19shieldingpolicyinwales AT lyonsronana costofimplementingthecovid19shieldingpolicyinwales AT porteralison costofimplementingthecovid19shieldingpolicyinwales AT watkinsalan costofimplementingthecovid19shieldingpolicyinwales AT williamsvictoria costofimplementingthecovid19shieldingpolicyinwales AT snookshelen costofimplementingthecovid19shieldingpolicyinwales |